Ferrer Internacional Overview
- Year Founded
-
1959
- Status
-
Private
- Employees
-
2,179
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$59.8M
Ferrer Internacional General Information
Description
Manufacturer of pharmaceutical products intended to treat serious and rare diseases. The company offers prescription medicines, active pharmaceutical ingredients, and research and development capabilities focused on pulmonary, vascular, interstitial, and rare neurological diseases, enabling healthcare providers and patients to access treatments for conditions with limited therapeutic options.
Contact Information
Website
www.ferrer.comCorporate Office
- Avenida Diagonal 549
- 5th Floor
- 08029 Barcelona
- Spain
Corporate Office
- Avenida Diagonal 549
- 5th Floor
- 08029 Barcelona
- Spain
Ferrer Internacional Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Debt - General | 11-Dec-2020 | $59.8M | Completed | Generating Revenue | ||
| 2. Debt Refinancing | 05-Aug-2020 | Completed | Generating Revenue | |||
| 1. Debt - General | 01-Jan-2017 | Completed | Generating Revenue |
Ferrer Internacional Comparisons
Industry
Financing
Details
Ferrer Internacional Competitors (54)
One of Ferrer Internacional’s 54 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| LEO Pharma | Private Equity-Backed | Ballerup, Denmark | ||||
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
Ferrer Internacional Patents
Ferrer Internacional Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-206870-Y | Cover perfected. | Inactive | 23-Oct-1974 |
Ferrer Internacional Signals
Ferrer Internacional Investments & Acquisitions (15)
Ferrer Internacional’s most recent deal was a Later Stage VC with Verge Labs. The deal was made on 02-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Verge Labs | 02-Oct-2024 | Later Stage VC | Drug Discovery | ||
| Ferrer (ASN90) | 22-Feb-2023 | Corporate Asset Purchase | Buildings and Property | ||
| ABAC Therapeutics | 15-Feb-2018 | Early Stage VC | Drug Discovery | ||
| Alexza Pharmaceuticals | 21-Jun-2016 | Merger/Acquisition | Pharmaceuticals | ||
| Prasfarma | 01-Apr-2016 | Merger/Acquisition | Pharmaceuticals |
Ferrer Internacional FAQs
-
When was Ferrer Internacional founded?
Ferrer Internacional was founded in 1959.
-
Where is Ferrer Internacional headquartered?
Ferrer Internacional is headquartered in Barcelona, Spain.
-
What is the size of Ferrer Internacional?
Ferrer Internacional has 2,179 total employees.
-
What industry is Ferrer Internacional in?
Ferrer Internacional’s primary industry is Pharmaceuticals.
-
Is Ferrer Internacional a private or public company?
Ferrer Internacional is a Private company.
-
What is Ferrer Internacional’s current revenue?
The current revenue for Ferrer Internacional is .
-
How much funding has Ferrer Internacional raised over time?
Ferrer Internacional has raised $314M.
-
Who are Ferrer Internacional’s competitors?
The Zambon Group, LEO Pharma, Chiesi Farmaceutici, BioMarin Pharmaceutical, and Pfizer (Vienna) are some of the 54 competitors of Ferrer Internacional.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process